Tomlinson, O. W., Mitchelmore, P., & Williams, C. A. (2024). Comparison of Reporting Quality in National Cystic Fibrosis Patient Registries: Implications for Identifying Use of Novel CFTR Modulators. Pulmonary Therapy, 10(4), 427. https://doi.org/10.1007/s41030-024-00274-y
Chicago Style (17th ed.) CitationTomlinson, Owen W., Philip Mitchelmore, and Craig A. Williams. "Comparison of Reporting Quality in National Cystic Fibrosis Patient Registries: Implications for Identifying Use of Novel CFTR Modulators." Pulmonary Therapy 10, no. 4 (2024): 427. https://doi.org/10.1007/s41030-024-00274-y.
MLA (9th ed.) CitationTomlinson, Owen W., et al. "Comparison of Reporting Quality in National Cystic Fibrosis Patient Registries: Implications for Identifying Use of Novel CFTR Modulators." Pulmonary Therapy, vol. 10, no. 4, 2024, p. 427, https://doi.org/10.1007/s41030-024-00274-y.